Vascular Biogenics Ltd. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
-
-
-
-
13,864.00
585
Cost of Goods Sold (COGS) incl. D&A
169.00
135.00
122.00
130.00
496.00
1,391
Gross Income
169.00
135.00
122.00
130.00
13,368.00
806
SG&A Expense
15,791.00
16,219.00
14,749.00
16,145.00
24,023.00
22,416
EBIT
15,960.00
16,354.00
14,871.00
16,275.00
10,655.00
23,222
Unusual Expense
1,638.00
2,342.00
-
-
-
-
Non Operating Income/Expense
-
1,286.00
101.00
22.00
209.00
1,893
Interest Expense
12.00
12.00
16.00
12.00
27.00
37
Pretax Income
17,370.00
17,407.00
14,888.00
16,002.00
10,138.00
20,458
Consolidated Net Income
17,370.00
17,407.00
14,888.00
16,002.00
10,138.00
20,458
Net Income
17,370.00
17,407.00
14,888.00
16,002.00
10,138.00
20,458
Net Income After Extraordinaries
17,370.00
17,407.00
14,888.00
16,002.00
10,138.00
20,458
Net Income Available to Common
17,370.00
17,407.00
14,888.00
16,002.00
10,138.00
20,458
EPS (Basic)
7.00
3.09
0.73
0.64
0.37
0.62
Basic Shares Outstanding
2,481.70
5,627.30
20,309.60
24,970.60
27,398.20
32,969.10
EPS (Diluted)
7.00
3.09
0.73
0.64
0.37
0.62
Diluted Shares Outstanding
2,481.70
5,627.30
20,309.60
24,970.60
27,398.20
32,969.10
EBITDA
15,791.00
16,219.00
14,749.00
16,145.00
10,499.00
22,066
Non-Operating Interest Income
240.00
15.00
100.00
263.00
335.00
908
About Vascular Biogenics
View Profile
